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Abstract: Liposarcomas correspond to the most common histological subtype of soft tissue sarcomas. They can be subdivided 
into:	well	differentiated	or	atypical	lipoma,	undifferentiated,	myxoid,	round,	and	pleomorphic	cells.	Atypical	lipomas	are	the	
most prevalent and usually appear as asymptomatic softened tumors. They are locally aggressive but rarely lead to distant 
metastases.	The	diagnosis	of	this	tumor	is	based	on	the	imaging	and	histopathologic	findings.	Treatment	consists	of	excision	
surgery with complete tumor removal. It has a good prognosis due to the low percentage of distant metastases. We report a 
rare case of giant atypical lipoma as well as the adopted therapy and evolution.




















tients.	The	deep	muscle	 tissue	of	extremities	 (especially	 thighs)	 is	
where	75%	of	the	cases	develop,	whereas	20%	of	the	cases	develop	




histological sub-types of liposarcoma: well differentiated or atypical 
lipoma,	 undifferentiated,	myxoid,	 round	 cells,	 and	 pleomorphic.4 
This	 histological	 differentiation	 is	 important,	 as	 it	 determines	 the	
prognosis and guides the treatment.5






the presence of a tumor in the left gluteal region for the previous 
year.	The	examination	revealed	a	soft,	multilobed	tumor,	measuring	
17	cm,	with	ulceration	(Figure	1).
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After	 carefully	 analyzing	 the	 surgical	piece,	 the	 anatomo-
pathological examination revealed an atypical lipomatous neo-















Well-differentiated	 liposarcomas	 (WDL)	 or	 atypical	 lipo-
mas	 (AL)	 represent	 40-45%	 of	 all	 liposarcomas,	 corresponding	 to	
the most common subgroup. The current recommendation is to call 
them	 atypical	 lipomas	 (when	 they	 affect	 surface	 tissues)	 or	 atyp-
ical	 lipomatous	 neoplasms	 (when	 they	 affect	 the	 deeper	 tissues).	
However,	 the	 terms	 are	 still	 used	 as	 synonyms,	 since,	depending	
on	the	location	(such	as	retroperitoneum	or	mediastinum),	the	term	
liposarcoma is more appropriate.7	AL	appears	as	a	slow-growth,	as-
ymptomatic	tumor.	It	 is	locally	aggressive,	but	rarely	leads	to	dis-
tant metastasis. The most common locations are extremities and ret-
roperitoneum.	The	retroperitoneal	forms	do	not	metastasize	either,	
unless they progress to undifferentiated forms.8
The pathogenesis is related to chromosomal aberrations. In 
WDL,	giant	markers	 and	 ring	 chromosomes	 are	 found	 in	 cytoge-
netic studies. These “neochromosomes” contain	 the	 amplification	
of	oncogenes	MDM-2	and	CDK-4	from	the	12q	13-15	chromosome	
region.	These	oncogenes	are	responsible	for	regulating	the	cell	cycle,	
leading to the disordered proliferation of atypical cells.5,8,9
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The diagnosis is based on image and histopathological ex-
aminations.	Examinations	such	as	computed	tomography	(CT)	and	
magnetic	resonance	(NMR)	may	be	performed	before	the	biopsy.	An	
NMR with or without contrast is usually recommended for lesions 
on	 extremities,	 and	 thorax,	 abdomen,	 and	 pelvic	 CT	 for	 patients	
with	 retroperitoneal/abdominal	 lesions.	Atypical	 lipomas	 appear	




The pathological examination reveals the proliferation of 
mature	adipocytes,	exhibiting	cell	size	variation,	focal	nuclear	atyp-
ia and/or fusiform cells. The presence of lipoblasts is not essential. 
Finding	 hyperchromatic	 stromal	 cells	 among	 the	 fibrous	 septa	 is	
an	important	clue	for	diagnosis.	This	finding,	along	with	immuno-
histochemistry	(positive	for	markers	MDM-2	and	CDK-4),	helps	to	
differentiate benign lipomas. The anatomopathological examination 
enables	 one	 to	 sub-classify	 the	WDL	 into	 four	 types:	 lipoma-like,	




The histological subtype and the location are the main prog-





Complete surgical removal of atypical lipomas is the prime 
treatment.	If	the	surgical	margins	are	impaired,	the	expectant	treat-
ment	may	be	 chosen,	 especially	 in	 cases	when	amplification	may	
lead	to	patient	morbidity.	The	WDL	should	not	be	subjected	to	ra-
FIgure 5: Four 
months after 
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apy lowers relapse rates but does not alter the global survival of 
the disease.8,10	Performing	adjuvant/neoadjuvant	chemotherapy	on	
well-differentiated liposarcomas and on undifferentiated liposarco-
mas is still controversial.10
In	short,	this	work	presents	a	literature	review	and	a	rare	case	
of	exuberant	well-differentiated	liposarcoma	on	a	young	patient,	 in	
order to offer medical advice in relation to the diagnosis of this neo-
plasm,	which	is	similar	to	benign	lipomas	and	angiolipomas,	tumors	
that	are	very	frequently	present	in	a	dermatologist’s	routine. q
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